Triple Take
September 01, 2008 | Jason Campbell

Plan sponsors seeking alternatives to long-only equity portfolios should consider long-short extension, equity market neutral and equity long-short strategies to increase returns and diversification.

Globalization, including the emerging market economies, has led to an increased opportunity set for global investors but at the same time, correlations among the world’s stock markets are increasing. As a result, equity portfolios diversified across the major economic regions have not experienced as much risk reduction as expected. One only has to look at the current “made in the U.S.A.” credit crisis and its impact on global markets to get a sense of how globalization is changing the road map for equity investors.

To offset this trend, investment managers and plan sponsors are increasingly looking at alternatives to the traditional long-only equity strategy for more efficient and less correlated portfolio construction methodologies. Three alternative equity-based strategies that are becoming increasingly common are long-short extension, equity market neutral and equity long-short. Each of these strategies uses leverage and actively shorts stocks, but does so through very different methods. Therefore, plan sponsors can look at each strategy on its own merits and determine its applicability to the plan’s specific circumstances.

There are a variety of academic and intuitive arguments for allowing investment managers to short stocks. For simplicity, let’s focus on the intuitive argument: long-only investment managers are not able to make efficient use of all of their research because they are prohibited from shorting stocks that they believe will underperform relative to the stock market and their long positions. The argument for removing the long-only constraint becomes even stronger considering that approximately 85% of the stocks in the S&P/TSX Composite Index have weights under 0.5% and approximately 90% in the Russell 1000 have weights under 0.2% (according to data from TSX Datalinx and UBS).

To demonstrate the impact of this issue, let’s assume that an investment manager is able to successfully find two different stocks that are both going to decline by 25% over the next 12 months. Despite having equally strong—and accurate, in this example—views on both stocks, the only option available to the long-only manager is not to hold either stock in the portfolio. In the example shown in Figure 1, this is akin to taking a -2.5% position in Company A stock and a -0.5% position in Company B stock, relative to the market index.

With a long-short strategy, the manager has the latitude to take a position in line with his or her conviction that the stock will decrease in price. The long-short manager can actively short Company B stock to take an active position of -2.5% relative to the index. This gives the manager the same opportunity as simply not holding Company A stock (due to its larger weight in the index). Relaxing the long-only constraint allows the long-short investment manager to profit equally from the negative views on stocks regardless of their respective weights in the index, resulting in more efficient use of the investment manager’s research.

1) Long-short Extension (130/30 Strategies) A long-short extension strategy removes the long-only constraint by a predetermined and constrained amount. Although the strategy can be set up in any predetermined ratio, the most common of late has been the 130/30 strategy. In combining a long-only portfolio with limited amounts of leverage and shorting, 130/30 strategies create a portfolio of both long and short equity positions, which, in combination, maintain a net market exposure equal to 100%. A 130/30 strategy will invest $130 in long stock positions and $30 in short stock positions for a net market exposure equal to $100.

Similar to a long-only strategy, the objective of a 130/30 strategy is to outperform an applicable equity benchmark. Additionally, if an investment manager offers both a longonly fund and a 130/30 fund using the same investment approach, a successful 130/30 fund should outperform the long-only version. Early indications suggest that 130/30 strategies have been able to add value relative to comparable long-only funds. However, data is limited, as most investment management firms have only recently introduced the strategy.

Latest news

CAAT returns 8.4% in 2025, net assets increase to $25.4 billion

The Colleges of Applied Arts and Technology pension plan is reporting a return of 8.4 per cent in 2025. The investment organization’s net assets under...

  • By: Staff
  • April 30, 2026 April 28, 2026
  • 11:00

Tracey Wong appointed to lead Fidelity Canada Institutional

Fidelity Canada has appointed Tracey Wong Vice President of Institutional Sales and Service. She now leads the firm’s institutional business in Canada across sales, consultant...

  • April 27, 2026 April 22, 2026
  • 09:00

Top 5 HR, benefits, pension and investment stories of the week

An article on Ottawa Community Housing Corp.’s benefits communication strategy was the most-read article on BenefitsCanada.com this past week. Here are the top five human...

  • By: Staff
  • April 24, 2026 April 23, 2026
  • 09:00

Coverage of the 2026 Women’s Health & Wealth Summit

As all aspects of employee well-being increasingly overlap, it’s never been more critical to look at the intersection between health and wealth, especially for a...

Today's top stories

Canadian institutional investors planning pullback from domestic equities: report

Canadian institutional investors are planning a major pullback from domestic stocks, with assets expected to shift mainly into global passive equities and alternatives, according to...

  • By: Staff
  • April 30, 2026 April 29, 2026
  • 15:00

CPP Investments relying on diversification to meet geopolitical uncertainty

At Canada Pension Plan Investments, the willingness to change your mind after meaningful world changes is just as important as the conviction of the rigorous...

High-cost, weight management drugs reshaping Canada’s private drug plans: report

A new generation of ultra-high-cost therapies is reshaping benefits plan risk, while the arrival of generic glucagon-like peptide-1 receptor agonist medications is set to shift...

  • By: Staff
  • April 29, 2026 April 28, 2026
  • 15:00

Report finds institutional investors improving gender balance, but gaps persist

While institutional investors made modest improvements in gender balance in 2026, progress continued to lag at the chief executive level, according to a report by...

  • By: Staff
  • April 29, 2026 April 30, 2026
  • 15:00